Shire HGT appoints Vickers as senior VP of R & D
Shire plc has named Philip J. Vickers as senior vice president of research and development for the company’s Human Genetic Therapies division in Cambridge.
Vickers joins Shire HGT from his previous role as chief scientific officer  and president of Resolvyx Pharmaceuticals Inc., a Bedford-based developer of anti-inflammatory drugs, where he oversaw business development and clinical research. Before that, he served as senior vice president and U.S. head of research at Boehringer Ingelheim GmbH, a therapeutics developer for cardiovascular, inflammatory and immunological disease. Additional roles included vice president of Pfizer Global Research and Development and head of Cambridge’s Pfizer Research Technology Center.